Legacy VC exits Radius Ventures wound down operations as of December 2024, presenting an opportunity to engage with the leadership on legacy assets, deal recaps, and potential successor vehicles or advisory roles through their connected teams.

Portfolio success Track record of healthcare tech investments across life sciences, diagnostics, medical devices, and healthcare IT indicates a network of potential co-investors, strategic acquirers, and founders who may be open to partnerships, advisory, or follow-on funding in related ventures.

Leadership continuity Key figures such as Jordan Davis and Daniel Lubin remain active in healthtech investing and family-office management, offering doors to deal sourcing, introductions to strategic buyers, and opportunities to discuss new venture concepts aligned with their expertise.

Industry focus Strong emphasis on healthcare innovation and digital health, enabling market-entry support, collaboration with portfolio companies, and selling points for enterprise clients seeking mature healthcare IT or diagnostics solutions.

Opportunity signals Past exits to major players (Aetna, GE Healthcare, Johnson & Johnson, Wolters Kluwer) and IPOs suggest credibility with large strategics. This can be leveraged to position advisory services, co-development, or partnerships around scale-ups in life sciences and med-tech.